alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with sch 23390 in 1 studies
| Studies (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Trials (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Recent Studies (post-2010) (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Studies (sch 23390) | Trials (sch 23390) | Recent Studies (post-2010) (sch 23390) |
|---|---|---|---|---|---|
| 90 | 1 | 2 | 803 | 0 | 585 |
| Protein | Taxonomy | alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50) | sch 23390 (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 1.0405 | |
| D | Rattus norvegicus (Norway rat) | 0.001 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.0461 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.0011 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0006 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.3891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booth, RG; Brown, RL; Bucholtz, EC; Tropsha, A; Wyrick, SD | 1 |
1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and sch 23390
| Article | Year |
|---|---|
Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ligands; Models, Molecular; Pyrilamine; Radioligand Assay; Structure-Activity Relationship; Tetrahydronaphthalenes | 1999 |